Resources
Big Molecule Watch
- Accord Biopharma Announces FDA Approval of IMULDOSA (ustekinumab-srlf) October 24, 2024 Daniel Farraye
- Federal Circuit Denies Injunction Pending Appeal After Amgen Beat Preliminary Injunction for Biosimilar Aflibercept October 23, 2024 Molly Grammel
- GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits October 23, 2024 Timothy Beavers|Harrison Gunn
- Teva’s Denosumab Biosimilar Candidate is Accepted for Review by FDA and EMA October 18, 2024 Seth Manilove
- Teva and mAbxience Add Additional Oncology Biosimilar Candidate, Expanding Strategic Partnership October 16, 2024 Jenevieve Nutovits
- Amgen Files BPCIA Complaint Against Fresenius Kabi Regarding Denosumab October 14, 2024 Sam Herron
- PTAB Institutes Eight More IPRs Filed by Merck on Johns Hopkins Pembrolizumab Patents October 7, 2024 Jie Lu|Yoko Bian
- Fresenius and Formycon Receive EC and FDA Approval of Ustekinumab Biosimilar October 5, 2024 Tara Thigpen|Stephanie Dusaban Gonzales
- Aflibercept Biosimilar Updates in Europe October 4, 2024 Stephanie Dusaban Gonzales
- Express Scripts Sues FTC Over Report on Pharmacy Benefit Management Industry October 3, 2024 Yoko Bian
BioPharma Reporter
- Alto Neuroscience’s depression drug trial fails at phase 2 October 24, 2024
- The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59 October 24, 2024
- Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors October 22, 2024
- Innovations in mass spectrometry accelerate the shift toward precision medicine October 22, 2024
- FDA approves targeted therapy for gastric cancer and its companion diagnostic October 22, 2024
- Wave claims first clinical RNA editing title in rare genetic disease October 17, 2024
- Investors and big pharma no longer avoiding techbio companies October 17, 2024
- FDA places hold on Novavax’s COVID-influenza combo vaccine October 17, 2024
- Merck opens new €290m U.S. biosafety testing facility October 15, 2024
- FDA approves Pfizer's antibody treatment for hemophilia October 15, 2024